Sell Aarrestad Provan
https://orcid.org/0000-0001-5442-902X
![](https://remedy-senter.no/templates/yootheme/cache/3f/Sella-Arrestad-Provan-3f024689.jpeg)
Education
- Doctor (MD) at the Faculty of Medicine, University of Oslo (1996)
- Doctoral degree (PhD) at the University of Oslo (2011)
Position
- Senior physician in rheumatology, Diakonhjemmet hospital
- Senior researcher, Clinic for rheumatology, outpatient clinic and research, Diakonhjemmet hospital
- Professor, section for public health, Innlandet University College
Field of interest
- Epidemiology, register data with a focus on comorbidities within inflammatory joint diseases and health economics
- Non-medicinal intervention research with the development of innovative digital tools for pre-treatment and monitoring
- Chronic pain conditions
- Biomarkers as outcome and surrogate marker for comorbidities
Other
- Co-leader work package 6 in REMEDY (Long-term follow-up)
Telephone
visiting address
Diakonhjemmet hospital
Diakonveien 12
0370 Oslo
Postal address
Diakohjemmet hospital
PO Box 23 Vinderen
0319 Oslo
Projects
NOECON
Health economics in the treatment of inflammatory arthritis diseases
Project Manager:
Sell Aarrestad ProvanProject Manager:
Tore K. KvienNor-vaC
Immunological response to COVID-19 vaccine in patients on immunosuppressive treatment
Project Manager:
Guro Løvik GollReMonit
remote monitoring of patients with spondyloarthritis
Project Manager:
Nina ØsteråsProject Manager:
Sell Aarrestad ProvanSQUEEZE
Maximizing the effect of prescription drugs in rheumatoid arthritis
Project Manager:
Espen A. HaavardsholmPublications
Publications taken from the National Science Archive (NVA):
Patient-reported outcomes in axial spondyloarthritis and psoriatic arthritis patients treated with secukinumab for 24 months in daily clinical practice
Seminars in Arthritis & Rheumatism
Developing and externally validating multinomial prediction models for methotrexate treatment outcomes in patients with rheumatoid arthritis: results from an international collaboration
Journal of Clinical Epidemiology
Incidence and outcome of COVID-19 following vaccine and hybrid immunity in patients on immunosuppressive therapy: identification of protective post-immunisation anti-RBD antibody levels in a prospective cohort study
RMD Open
Cut-Offs for Disease Activity States in Axial Spondyloarthritis With Ankylosing Spondylitis Disease Activity Score (ASDAS) Based on C-Reactive Protein and ASDAS Based on Erythrocyte Sedimentation Rate: Are They Interchangeable?
Journal of Rheumatology
Follow-Up of Patients With Axial Spondyloarthritis in Specialist Health Care With Remote Monitoring and Self-Monitoring Compared With Regular Face-to-Face Follow-Up Visits (the ReMonit Study): Protocol for a Randomized, Controlled Open-Label Noninferiority Trial
JMIR Research Protocols
Non-steroidal anti-inflammatory drugs and risk of pulmonary embolism in patients with inflammatory joint disease—results from the nationwide Norwegian Cardio-rheuma registry
European Heart Journal (EHJ) - Cardiovascular Pharmacotherapy
How does current disease activity in rheumatoid arthritis affect the short-term risk of acute coronary syndrome? A clinical register based study from Sweden and Norway
European journal of internal medicine
Uptake and effectiveness of newer biologic and targeted synthetic disease-modifying antirheumatic drugs in psoriatic arthritis: results from five Nordic biologics registries
Annals of the Rheumatic Diseases
Exposure to specific tumor necrosis factor inhibitors and risk of demyelinating and inflammatory neuropathy in cohorts of patients with inflammatory arthritis: a collaborative observational study across five Nordic rheumatology registers
RMD Open
One-Year Treatment Outcomes of Secukinumab Versus Tumor Necrosis Factor Inhibitors in Spondyloarthritis: Results From Five Nordic Biologic Registries Including More Than 10,000 Treatment Courses
Arthritis care & research
Short-term, intermediate-term and long-term risks of acute coronary syndrome in cohorts of patients with RA starting biologic DMARDs: Results from four Nordic countries
Annals of the Rheumatic Diseases
Serious infections in patients with rheumatoid arthritis and psoriatic arthritis treated with tumor necrosis factor inhibitors: data from register linkage of the NOR-DMARD study
Annals of the Rheumatic Diseases
High-Intensity Exercise Improves Fatigue, Sleep, and Mood in Patients With Axial Spondyloarthritis: Secondary Analysis of a Randomized Controlled Trial
Physical Therapy
Fatigue is cross-sectionally not associated with objective assessments of inflammation, but changes in fatigue are associated with changes of disease activity assessments during biologic treatment of patients with established rheumatoid arthritis
Clinical Rheumatology
Treatment retention of infliximab and etanercept originators versus their corresponding biosimilars: Nordic collaborative observational study of 2334 biologics naive patients with spondyloarthritis
RMD Open
Swollen, but not tender joints, are independently associated with ultrasound synovitis: Results from a longitudinal observational study of patients with established rheumatoid arthritis
Annals of the Rheumatic Diseases
High intensity exercise for 3 months reduces disease activity in axial spondyloarthritis (axSpA): A multicentre randomized trial of 100 patients
British Journal of Sports Medicine
Opportunities and challenges for real-world studies on chronic inflammatory joint diseases through data enrichment and collaboration between national registers: the Nordic example
RMD Open
Calcium supplementation and inflammation increase mortality in rheumatoid arthritis: A 15-year cohort study in 609 patients from the Oslo Rheumatoid Arthritis Register
Seminars in Arthritis & Rheumatism
CRP and ASDAS are associated with future elevated arterial stiffness, a risk marker of cardiovascular disease, in patients with ankylosing spondylitis: Results after 5-year follow-up
Annals of the Rheumatic Diseases
Disease activity in ankylosing spondylitis and associations to markers of vascular pathology and traditional cardiovascular disease risk factors: A cross-sectional study
Journal of Rheumatology
The impact of newer biological disease modifying anti-rheumatic drugs on cardiovascular risk factors: A 12-month longitudinal study in rheumatoid arthritis patients treated with rituximab, abatacept and tociliziumab
PLOS ONE
Circulating levels of inflammatory cytokines and cytokine receptors in patients with ankylosing spondylitis: A cross-sectional comparative study
Scandinavian Journal of Rheumatology
Effect of 1-Year Anti-TNF-alpha Therapy on Aortic Stiffness, Carotid Atherosclerosis, and Calprotectin in Inflammatory Arthropathies: A Controlled Study
American Journal of Hypertension